Search research articles
Contact Us
Filters
Showing results (151-160 of 167) with videos related to
Page
of 17
Sort By:
Nature Communications
|
January 16, 2021
The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair
Ayesha A Shafi, Chris M McNair, Jennifer J McCann, et al.
BMC Psychiatry
|
August 7, 2013
Study protocol for the randomised controlled trial: antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study)
R Hamish McAllister-Williams, Eleanor Smith, Ian M Anderson, et al.
BJC Reports
|
March 27, 2025
A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancers
Peter Gallagher, Christian Rolfo, Elena Elez, et al.
Wellcome Open Research
|
February 23, 2021
Metformin as adjunctive therapy for dengue in overweight and obese patients: a protocol for an open-label clinical trial (MeDO)
Nguyet Minh Nguyen, Ho Quang Chanh, Dong Thi Hoai Tam, et al.
Bipolar Disorders
|
September 7, 2019
Affective cognition in bipolar disorder: A systematic review by the ISBD targeting cognition task force
Kamilla W Miskowiak, Ida Seeberg, Hanne L Kjaerstad, et al.
Cancer Discovery
|
April 21, 2021
RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced Disease
Amy C Mandigo, Wei Yuan, Kexin Xu, et al.
Biorxiv : the Preprint Server for Biology
|
August 30, 2024
A Ketogenic Diet Sensitizes Pancreatic Cancer to Inhibition of Glutamine Metabolism
Omid Hajihassani, Mehrdad Zarei, Asael Roichman, et al.
BMC Cancer
|
April 11, 2025
A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC)
Francesca Aroldi, Elena Elez, Thierry André, et al.
Arthritis Care & Research
|
December 20, 2016
Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome: Capturing the Discrepancy
Oriana M Bezzina, Peter Gallagher, Sheryl Mitchell, et al.
Bipolar Disorders
|
August 11, 2022
Can magnetic resonance imaging enhance the assessment of potential new treatments for cognitive impairment in mood disorders? A systematic review and position paper by the International Society for Bipolar Disorders Targeting Cognition Task Force
Kamilla W Miskowiak, Nefize Yalin, Ida Seeberg, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 167) with videos related to
Sort By:
Page
of 17
Nature Communications
|
January 16, 2021
The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair
Ayesha A Shafi, Chris M McNair, Jennifer J McCann, et al.
BMC Psychiatry
|
August 7, 2013
Study protocol for the randomised controlled trial: antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study)
R Hamish McAllister-Williams, Eleanor Smith, Ian M Anderson, et al.
BJC Reports
|
March 27, 2025
A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancers
Peter Gallagher, Christian Rolfo, Elena Elez, et al.
Wellcome Open Research
|
February 23, 2021
Metformin as adjunctive therapy for dengue in overweight and obese patients: a protocol for an open-label clinical trial (MeDO)
Nguyet Minh Nguyen, Ho Quang Chanh, Dong Thi Hoai Tam, et al.
Bipolar Disorders
|
September 7, 2019
Affective cognition in bipolar disorder: A systematic review by the ISBD targeting cognition task force
Kamilla W Miskowiak, Ida Seeberg, Hanne L Kjaerstad, et al.
Cancer Discovery
|
April 21, 2021
RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced Disease
Amy C Mandigo, Wei Yuan, Kexin Xu, et al.
Biorxiv : the Preprint Server for Biology
|
August 30, 2024
A Ketogenic Diet Sensitizes Pancreatic Cancer to Inhibition of Glutamine Metabolism
Omid Hajihassani, Mehrdad Zarei, Asael Roichman, et al.
BMC Cancer
|
April 11, 2025
A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC)
Francesca Aroldi, Elena Elez, Thierry André, et al.
Arthritis Care & Research
|
December 20, 2016
Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome: Capturing the Discrepancy
Oriana M Bezzina, Peter Gallagher, Sheryl Mitchell, et al.
Bipolar Disorders
|
August 11, 2022
Can magnetic resonance imaging enhance the assessment of potential new treatments for cognitive impairment in mood disorders? A systematic review and position paper by the International Society for Bipolar Disorders Targeting Cognition Task Force
Kamilla W Miskowiak, Nefize Yalin, Ida Seeberg, et al.
Page
of 17